{"version":"1.0","type":"link","title":"Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study.","author_name":"Duan JC 외","author_url":"https://prs-insight.online/author/Duan%20JC","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/96257","thumbnail_width":1200,"thumbnail_height":630}